SalvaRx Group plc 28 February 2017 28 February 2017 SalvaRx Group plc Investment in Nekonal SalvaRx Group plc is pleased to announce that its...
SalvaRx Group plc 02 February 2017 SalvaRx Group plc ("SalvaRx" or "the Company") Intensity Therapeutics Inc. The Company...
SalvaRx Group plc 03 October 2016 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
SalvaRx Group plc 03 October 2016 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...
SalvaRx Group plc 14 September 2016 SalvaRx Group plc ("SalvaRx" or "the Company") Corporate Video SalvaRx (LON: SALV), the...
SalvaRx Group plc 13 September 2016 SalvaRx Group plc ("SalvaRx" or the "Company") Half Yearly Report to 30 June 2016 SalvaRx...
SalvaRx Group plc 22 August 2016 DRAFT Press Release 22 August 2016 SalvaRx Group plc ("SalvaRx" or the "Company") Drug...
SalvaRx Group plc 04 August 2016 SalvaRx Group plc ("SalvaRx" or "the Company") Result of AGM SalvaRx (LON: SALV), the drug...
SalvaRx Group plc 27 June 2016 Press Release 27 June 2016 SalvaRx Group plc ("SalvaRx" or the "Company" or the...
SalvaRx Group plc 22 April 2016 Press Release 22 April 2016 SalvaRx Group plc ("SalvaRx" or the "Company") Investment in...
SalvaRx Group plc 21 April 2016 21 April 2016 SalvaRx Group plc ("SalvaRx" or the "Company") Grant funding from the European...
SalvaRx Group plc 29 March 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or SalvaRx Group plc the underlying...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.